Neuroquímida y Neurodegeneración
University of Birmingham
Birmingham, Reino UnidoUniversity of Birmingham-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2024
-
Correction to: The mycobacterial glycoside hydrolase LamH enables capsular arabinomannan release and stimulates growth (Nature Communications, (2024), 15, 1, (5740), 10.1038/s41467-024-50051-3)
Nature Communications
-
The mycobacterial glycoside hydrolase LamH enables capsular arabinomannan release and stimulates growth
Nature Communications, Vol. 15, Núm. 1
2021
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
2019
-
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344
-
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight
Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863
2014
-
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Nature Genetics, Vol. 46, Núm. 9, pp. 989-993